Patient-derived cervical cancer organoids recapitulated the main elements of the original patient tumor. Drug screening and radiotherapy of organoids facilitate access to patient tumor radiation sensitivity and chemotherapy prediction. Patient-derived cervical cancer organoids could be used as a personalized medicine confirmation tool.,
Journal of Gynecologic Oncology.
2022;34(3):e35. doi: 10.3802/jgo.2023.34.e35